OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
Go back to OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 298.41 -0.09 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $298.50 | 52 Week High | $139.79 | |||
| Open | $300.44 | 52 Week Low | $82.07 | |||
| Day High | $302.44 | P/E | 693.98 | |||
| Day Low | $296.08 | EPS | $0.43 | |||
| Volume | 242,190 | |||||
| (NASDAQ: OABI) | Delayed: 4.79 -0.13 (2.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $ | |||
| Open | $4.90 | 52 Week Low | $ | |||
| Day High | $5.00 | P/E | N/A | |||
| Day Low | $4.69 | EPS | $ | |||
| Volume | 1,051,021 | |||||

